Plasma Cell Differentiation
Plasma Cell Differentiation - Related Videos
02:20
Stimulating Nerve Stem Cell Differentiation Using Cold Atmospheric Plasma Treatment
0 Views •
2025
This video presents a method for triggering differentiation in neural stem cells by utilizing cold atmospheric plasma. This generates UV radiation and reactive molecules to stimulate nerve cells to produce projections, indicating neuronal cell differentiation.
10:26
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
0 Views •
Cited by 10 •
2019
Using multi-step culture systems, we report an in vitro B cell to plasma cell differentiation model.
11:06
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
0 Views •
Cited by 2 •
2017
Epigenetic factors can interact with genetic programs to modulate gene expression and regulate B cell function. By combining in vitro B-cell stimulation, qRT-PCR, and high-throughput microRNA-sequence and mRNA-sequence approaches, we can analyze the epigenetic modulation of miRNA and gene expression in B cells.
07:37
Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
0 Views •
Cited by 66 •
2017
A high-throughput cold physical plasma treatment protocol of liquids and cells is shown. It involves setting up different feed gas compositions for plasma ignition, measuring the plasma's emission spectra, and the subsequent analysis of liquids and cellular activity after plasma treatment.
05:58
Plasma Lithography Surface Patterning for Creation of Cell Networks
0 Views •
Cited by 16 •
2011
A versatile plasma lithography technique has been developed to generate stable surface patterns for guiding cellular attachment. This technique can be applied to create cell networks including those that mimic natural tissues and has been used for studying several, distinct cell types.
FAQs
BLIMP-1 serves as a regulator of transcriptional reprogramming during plasma cell differentiation. By suppressing the mature B-cell program, it helps redirect an activated B lymphocyte away from its previous state. This regulatory change is important for understanding how cells acquire the specialized program associated with high-volume antibody secretion.
XBP1 supports expansion of the endoplasmic reticulum and the protein-secretion machinery. That support equips the developing cell to handle the demands associated with producing large amounts of antibody. In experimental studies, XBP1 therefore represents a key connection between transcriptional reprogramming and the cell's secretory capacity.
Antigen recognition provides important context for the response, while T-cell help often contributes additional support. Plasma cell differentiation can therefore be studied in relation to both influences rather than as an isolated cellular event. This context helps explain how adaptive immune responses develop after antigen exposure.
Two linked changes are especially informative: suppression of the mature B-cell program by BLIMP-1 and XBP1-supported expansion of the endoplasmic reticulum and secretion machinery. Examining these events connects gene regulation with antibody-production capacity, allowing studies to follow differentiation from an activated B-cell state toward a cell specialized for substantial antibody release.
During infection, the process helps researchers understand how antibody responses develop as part of adaptive immunity. In vaccination research, the same framework helps clarify how exposure to an antigen can lead toward antibody-producing cells. The topic therefore connects cellular changes in B lymphocytes with development of adaptive immune responses.
Its relevance extends beyond normal immune responses. Studying the process can inform work on immune deficiencies, autoimmune disease, persistent infections, and plasma-cell malignancies such as multiple myeloma. These settings make the differentiation program a useful context for asking how antibody-producing cells relate to impaired, misdirected, enduring, or malignant immune states.